Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0063 | 0.2925 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.1191 | 0.1191 |
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 0.353 | 0.353 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0197 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0052 | 0.2218 | 0.6283 |
Echinococcus multilocularis | tar DNA binding protein | 0.0073 | 0.353 | 0.353 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.0197 | 0.0197 |
Echinococcus multilocularis | geminin | 0.0177 | 1 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0073 | 0.353 | 1 |
Brugia malayi | TAR-binding protein | 0.0073 | 0.353 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.0197 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0073 | 0.353 | 0.353 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0197 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 0.353 | 0.353 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0.0197 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0063 | 0.2925 | 0.2925 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.002 | 0.0197 | 0.5 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0063 | 0.2925 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 0.353 | 0.353 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0063 | 0.2925 | 0.2925 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0052 | 0.2218 | 0.6283 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0073 | 0.353 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.0197 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0052 | 0.2218 | 0.6283 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 1 | 1 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0197 | 0.5 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0063 | 0.2925 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 0.353 | 0.353 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 1 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0197 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0063 | 0.2925 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0197 | 0.5 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0197 | 0.0197 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.0197 | 0.0559 |
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 0.353 | 0.353 |
Brugia malayi | RNA binding protein | 0.0073 | 0.353 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0197 | 0.0197 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0197 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.2218 | 0.6283 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.0197 | 0.0197 |
Loa Loa (eye worm) | RNA binding protein | 0.0073 | 0.353 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1191 | 0.3375 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0.0197 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0073 | 0.353 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0063 | 0.2925 | 0.2925 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.002 | 0.0197 | 0.0559 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.1191 | 0.3375 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0063 | 0.2925 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0063 | 0.2925 | 0.2925 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0063 | 0.2925 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.